Answers are grounded in this paper and cite their sources.
This survey found no major concerns regarding the safety and effectiveness of vibegron in Japanese OAB patients, except for urinary retention-related AEs. Vibegron is considered to represent a useful drug for treating OAB symptoms in a real-world clinical setting.
No takes yet. Share an insight, caveat, or question.
Yoshimura et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: